ESMO 2022 Conference Coverage

 

ESMO 2022 Conference Coverage
J

Lecture Summary - ESMO 2022 on 4.5-Year Follow-Up From KEYNOTE-240: Pembrolizumab vs Placebo as 2L Treatment for Sorafenib-Treated aHCC

By ESMO 2022 Conference Coverage FEATURING Julien Edeline
By ESMO 2022 Conference Coverage FEATURING Julien Edeline
10 views
September 16, 2022
Comments 0
Login to view comments. Click here to Login
GI
07:10

ESMO 2022 on ctDNA Dynamics, CEA, and Sites of Recurrence for the Ra…

ESMO 2022 Conference Coverage

J. Tie

448 views
01:21

Lecture Summary - ESMO 2022 on Characterizing the Clinico-Genomic La…

ESMO 2022 Conference Coverage

F. Keane

18 views
05:27

ESMO 2022 on Characterizing the Clinico-Genomic Landscape and Outcom…

ESMO 2022 Conference Coverage

F. Keane

60 views
01:01

Lecture Summary - ESMO 2022 on the NuTide:302 Study: NUC-3373, a Pro…

ESMO 2022 Conference Coverage

A. Coveler

14 views
04:14

ESMO 2022 on the NuTide:302 Study: NUC-3373, a ProTide Transformatio…

ESMO 2022 Conference Coverage

A. Coveler

73 views
09:14

ESMO 2022 on the Global Phase 3 Multiregional Clinical Trial FRESCO-…

ESMO 2022 Conference Coverage

A. Dasari

254 views
06:14

ESMO 2022 on the Phase 3 HIMALAYA Study: Impact of Viral Aetiology o…

ESMO 2022 Conference Coverage

S. L. Chan

79 views
12:50

ESMO 2022 on KRYSTAL-1: Updated Efficacy & Safety of Adagrasib With/…

ESMO 2022 Conference Coverage

S. Klempner

206 views
43

Lecture Summary - ESMO 2022 on the Global Phase 3 Multiregional Clin…

ESMO 2022 Conference Coverage

A. Dasari

13 views
42

Lecture Summary - ESMO 2022 on the Updated Analysis of DESTINY-Gastr…

ESMO 2022 Conference Coverage

G. Ku

9 views
05:29

ESMO 2022 Updated Analysis of DESTINY-Gastric02 Trial: T-DXd in West…

ESMO 2022 Conference Coverage

G. Ku

188 views
01:26

Lecture Summary - ESMO 2022 on the Phase III ERMES Study: FOLFIRI/Ce…

ESMO 2022 Conference Coverage

A. Orlandi

24 views
12:14

ESMO 2022 on the Phase III ERMES Study: FOLFIRI/Cetuximab vs. FOLFIR…

ESMO 2022 Conference Coverage

A. Orlandi

219 views
03:47

ESMO 2022: Early Decreases in KRAS Mutant Allele Frequency Predicts …

ESMO 2022 Conference Coverage

H. Lenz

58 views
01:35

Lecture Summary - ESMO 2022: Beyond 1L for mCRC - Best Practices and…

ESMO 2022 Conference Coverage

T. Price

18 views
20:07

Beyond 1L for mCRC - Best Practices and Practical Nuances

Timothy Price

311 views
16:12

ESMO 2022 on Advances in HER2-Targeted Therapy or Novel Targeted The…

ESMO 2022 Conference Coverage

K. Shitara

277 views
18

Lecture Summary - ESMO 2022: Real-World Monitoring of ctDNA Reliably…

ESMO 2022 Conference Coverage

S. Cohen

17 views
05:42

ESMO 2022: Real-World Monitoring of ctDNA Reliably Predicts Cancer R…

ESMO 2022 Conference Coverage

S. Cohen

330 views
09:24

ESMO 2022 Final Analysis of the Randomized, Phase 3 RATIONALE-301 St…

ESMO 2022 Conference Coverage

M. Kudo

104 views
04:44

ESMO 2022 on the Updated OS From the Phase 3 TOPAZ-1 Study: Durvalum…

ESMO 2022 Conference Coverage

D. Oh

167 views
46

Lecture Summary - ESMO 2022 on 4.5-Year Follow-Up From KEYNOTE-240: …

ESMO 2022 Conference Coverage

J. Edeline

10 views
04:28

ESMO 2022 on 4.5-Year Follow-Up From KEYNOTE-240: Pembrolizumab vs. …

ESMO 2022 Conference Coverage

J. Edeline

122 views
13:16

ESMO 2022 on the NICHE-2 Study: Neoadjuvant Immune Checkpoint Inhibi…

ESMO 2022 Conference Coverage

M. Chalabi

919 views
19

Lecture Summary - ESMO 2022 on the HIPECT4 Randomized Phase 3 Study:…

ESMO 2022 Conference Coverage

A. Arjona-Sanchez

22 views
05:02

ESMO 2022 on the HIPECT4 Randomized Phase 3 Study: Adjuvant Hyperthe…

ESMO 2022 Conference Coverage

A. Arjona-Sanchez

855 views
22

Lecture Summary - ESMO 2022 on the SAMCO-PRODIGE 54 Randomised Phase…

ESMO 2022 Conference Coverage

J. Taieb

10 views
06:19

ESMO 2022 on the SAMCO-PRODIGE 54 Randomised Phase II Trial: Aveluma…

ESMO 2022 Conference Coverage

J. Taieb

216 views